Dabigatran
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University College, London
Overview
Dabigatran is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Dabigatran clinical trials
Explore related
Medical disclaimer. This page summarizes research about Dabigatran for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.